The Harvest Podcast November 21, 2024 Audio only 15:18 CEO INTERVIEW: AnnovisBio, Inc. ($ANVS) gets FDA green light to initiate Phase 3 Alzheimer's study In this episode, Dr. Maccecchini discusses the company’s recent meetings with the U.S. Food and Drug Administration... Carmel Fisher